RecruitingPhase 2NCT03708900
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
Studying Adrenal Cushing syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- RECORDATI GROUP
- Principal Investigator
- Recordati AGRecordati AG
- Intervention
- LCI699(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 2-17 years · All sexes
- Timeline
- 2021 – 2027
Study locations (15)
- University of California San Francisco UCSF, San Francisco, California, United States
- ABMED Clinical Research Corp, Cape Coral, Florida, United States
- Ann & Robert H. Lurie Children's Hospital, Chicago, Illinois, United States
- National Institute of Child Health and Human Development, Bethesda, Maryland, United States
- Texas Valley Clinical Research, Weslaco, Texas, United States
- UZ Brussel, Jette, Brussels Capital, Belgium
- Multiprofile Hospital for Active Treatment Sveta Marina EAD, Varna, Bulgaria
- Hospital Necker Enfants Malades, Paris, France
- Robert Debre Hospital, Paris, France
- CHU Bicetre APHP Paris Saclay, Paris, France
- Aziendal Ospedaliero Universitaria Pisana Presidio Ospedale di Cisanello, Pisa, PI, Italy
- Ospedale Bambino Gesu, Roma, Italy
- University Clinical Center Ljubljana, Ljubljana, Slovenia
- Alder Hey Childrens NHS Foundation Trust, Liverpool, United Kingdom
- The Royal London Childrens Hospital, London, United Kingdom
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03708900 on ClinicalTrials.govOther trials for Adrenal Cushing syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07168122Establishment and Clinical Application of Reference Intervals of Salivary CortisolShanghai 6th People's Hospital
- RECRUITINGNANCT06250699A Single Center Randomized Controlled Study on the Promotion of Rapid RecoveryZhe Meng
- RECRUITINGNANCT05911620Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous HypercorticismCentral Hospital, Nancy, France
- RECRUITINGNANCT05881005NAC- NAFLD and CushingUniversity Hospital, Angers
- RECRUITINGNCT06050057Surgical Treatment of Adrenal Diseases- Laparoscopic vs. Robotic-assisted AdrenalectomyUniversity Hospital Olomouc
- RECRUITINGNCT05521529Cushing's Syndrome Before and After Treatment (CORRECT)University of Aarhus
- ACTIVE NOT RECRUITINGNCT05446779Postmortem Evaluation of Adrenal and Other Endocrine Tumors in Patients With Sudden DeathHelsinki University Central Hospital
- RECRUITINGPHASE4NCT06801249Effect of Metyrapone on Cardiovascular Risk Factors in Patients With Adrenal Incidentalomas and Cushing's SyndromeIRCCS Azienda Ospedaliero-Universitaria di Bologna